{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T05:46:26Z","timestamp":1794721586247,"version":"4.9.1"},"reference-count":29,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute of Health Research, UK","doi-asserted-by":"crossref","award":["17\/63\/131"],"award-info":[{"award-number":["17\/63\/131"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2021,8,22]]},"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The utility of HbA1c (glycosylated hemoglobin) to estimate glycemic control in populations of African and other low-resource countries has been questioned because of high prevalence of other medical conditions that may affect its reliability. Using continuous glucose monitoring (CGM), we aimed to determine the comparative performance of HbA1c, fasting plasma glucose (FPG) (within 5 hours of a meal) and random non-fasting glucose (RPG) in assessing glycemic burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>We assessed the performance of HbA1c, FPG and RPG in comparison to CGM mean glucose in 192 Ugandan participants with type 2 diabetes. Analysis was undertaken in all participants, and in subgroups with and without medical conditions reported to affect HbA1c reliability. We then assessed the performance of FPG and RPG, and optimal thresholds, in comparison to HbA1c in participants without medical conditions thought to alter HbA1c reliability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>32.8% (63\/192) of participants had medical conditions that may affect HbA1c reliability: anemia 9.4% (18\/192), sickle cell trait and\/or hemoglobin C (HbC) 22.4% (43\/192), or renal impairment 6.3% (12\/192). Despite high prevalence of medical conditions thought to affect HbA1c reliability, HbA1c had the strongest correlation with CGM measured glucose in day-to-day living (0.88, 95% CI 0.84 to 0.91), followed by FPG (0.82, 95% CI 0.76 to 0.86) and RPG (0.76, 95% CI 0.69 to 0.81). Among participants without conditions thought to affect HbA1c reliability, FPG and RPG had a similar diagnostic performance in identifying poor glycemic control defined by a range of HbA1c thresholds. FPG of \u22657.1 mmol\/L and RPG of \u226510.5 mmol\/L correctly identified 78.2% and 78.8%, respectively, of patients with an HbA1c of \u22657.0%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HbA1c is the optimal test for monitoring glucose control even in low-income and middle-income countries where medical conditions that may alter its reliability are prevalent; FPG and RPG are valuable alternatives where HbA1c is not available.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2021-002350","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T12:07:40Z","timestamp":1631880460000},"page":"e002350","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0939-9380","authenticated-orcid":false,"given":"Anxious J","family":"Niwaha","sequence":"first","affiliation":[{"name":"Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK"},{"name":"NCD Theme, MRC\/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren R","family":"Rodgers","sequence":"additional","affiliation":[{"name":"Institute of Health Research, University of Exeter Medical School, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamund","family":"Greiner","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla A","family":"Balungi","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK"},{"name":"NCD Theme, MRC\/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Mwebaze","sequence":"additional","affiliation":[{"name":"Department of Medicine, St. Francis Hospital Nsambya, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3559-6660","authenticated-orcid":false,"given":"Timothy J","family":"McDonald","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5620-473X","authenticated-orcid":false,"given":"Andrew T","family":"Hattersley","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3785-327X","authenticated-orcid":false,"given":"Beverley M","family":"Shields","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moffat J","family":"Nyirenda","sequence":"additional","affiliation":[{"name":"NCD Theme, MRC\/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda"},{"name":"NCD Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus G","family":"Jones","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"2025073111554255000_9.1.e002350.1","unstructured":"Federation ID . IDF diabetes atlas. 9th edition, 2019."},{"key":"2025073111554255000_9.1.e002350.2","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1795"},{"key":"2025073111554255000_9.1.e002350.3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/IJGM.S124548","article-title":"Frequency and predictors of suboptimal glycemic control in an African diabetic population","volume":"10","author":"Kibirige","year":"2017","journal-title":"Int J Gen Med"},{"key":"2025073111554255000_9.1.e002350.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.10.018"},{"key":"2025073111554255000_9.1.e002350.5","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-018-3480-9","article-title":"Assessment of glycemic control in type 2 diabetes in the eastern Sudan","volume":"11","author":"Omar","year":"2018","journal-title":"BMC Res Notes"},{"key":"2025073111554255000_9.1.e002350.6","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-S006"},{"key":"2025073111554255000_9.1.e002350.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1575"},{"key":"2025073111554255000_9.1.e002350.8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-8587(17)30181-X","article-title":"Diabetes in sub-Saharan Africa: from clinical care to health policy","volume":"5","author":"Atun","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025073111554255000_9.1.e002350.9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4239\/wjd.v11.i8.358","article-title":"Access to insulin delivery devices and glycated haemoglobin in lower-income countries","volume":"11","author":"Klatman","year":"2020","journal-title":"World J Diabetes"},{"key":"2025073111554255000_9.1.e002350.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.21035"},{"key":"2025073111554255000_9.1.e002350.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3599-3"},{"key":"2025073111554255000_9.1.e002350.12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/1753-0407.12843","article-title":"Discordance between HbA1c and glycemia","volume":"10","author":"Misra","year":"2018","journal-title":"J Diabetes"},{"key":"2025073111554255000_9.1.e002350.13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011692"},{"key":"2025073111554255000_9.1.e002350.14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S2213-8587(18)30074-3","article-title":"Blood glucose meters and test strips: global market and challenges to access in low-resource settings","volume":"7","author":"Klatman","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025073111554255000_9.1.e002350.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.10.001"},{"key":"2025073111554255000_9.1.e002350.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6093595","article-title":"Access to hemoglobin A1c in rural Africa: a difficult reality with severe consequences","volume":"2018","author":"Park","year":"2018","journal-title":"J Diabetes Res"},{"key":"2025073111554255000_9.1.e002350.17","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.12391"},{"key":"2025073111554255000_9.1.e002350.18","doi-asserted-by":"crossref","DOI":"10.1186\/s13690-015-0088-6","article-title":"Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis","volume":"73","author":"Ketema","year":"2015","journal-title":"Arch Public Health"},{"key":"2025073111554255000_9.1.e002350.19","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/jn\/129.9.1669","article-title":"World Health organization hemoglobin cut-off points for the detection of anemia are valid for an Indonesian population","volume":"129","author":"Khusun","year":"1999","journal-title":"J Nutr"},{"key":"2025073111554255000_9.1.e002350.20","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.9.1313"},{"key":"2025073111554255000_9.1.e002350.21","unstructured":"NGSP . HbA1c methods: effects of hemoglobin variants (HbC, HbS, HbE and HbD traits) and elevated fetal hemoglobin (HbF) 2020."},{"key":"2025073111554255000_9.1.e002350.22","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2017-204755"},{"key":"2025073111554255000_9.1.e002350.23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002383"},{"key":"2025073111554255000_9.1.e002350.24","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.2.275"},{"key":"2025073111554255000_9.1.e002350.25","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1774"},{"key":"2025073111554255000_9.1.e002350.26","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.335"},{"key":"2025073111554255000_9.1.e002350.27","first-page":"134","article-title":"Comparison of fasting blood glucose & post prandial blood glucose with HbA1c in assessing the glycemic control","volume":"2","author":"Swetha","year":"2014","journal-title":"International J of Healthcare and Biomedical Research"},{"key":"2025073111554255000_9.1.e002350.28","first-page":"491","article-title":"Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta national Hospital","volume":"79","author":"Otieno","year":"2002","journal-title":"East Afr Med J"},{"key":"2025073111554255000_9.1.e002350.29","article-title":"The sickle effect: the silent titan affecting glycated hemoglobin reliability","volume":"12","author":"Gordon","year":"2020","journal-title":"Cureus"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2021-002350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T18:55:50Z","timestamp":1753988150000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2021-002350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,9,17]]},"published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1136\/bmjdrc-2021-002350"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2021-002350","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}